EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Mitochondrial Basis for Heart Failure Progression

William D Watson iD, Per M Arvidsson, Jack J J Miller, Andrew J Lewis, Oliver J Rider

Cardiovascular Drugs and Therapy · 2024

DOI: 10.1007/s10557-024-07582-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Drugs and Therapy, 2024. Verfasst von William D Watson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK. ww265@cam.ac.uk. Hauptthemen laut MEDLINE: Heart Failure, Mitochondria, Heart, Disease Progression, Oxidative Stress. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In health, the human heart is able to match ATP supply and demand perfectly. It requires 6 kg of ATP per day to satisfy demands of external work (mechanical force generation) and internal work (ion movements and basal metabolism). The heart is able to link supply with demand via direct responses to ADP and AMP concentrations but calcium concentrations within myocytes play a key role, signalling both inotropy, chronotropy and matched increases in ATP production. Calcium/calmodulin-dependent protein kinase (CaMKII) is a key adapter to increased workload, facilitating a greater and more rapid calcium concentration change. In the failing heart, this is dysfunctional and ATP supply is impaired. This review aims to examine the mechanisms and pathologies that link increased energy demand to this disrupted situation. We examine the roles of calcium loading, oxidative stress, mitochondrial structural abnormalities and damage-associated molecular patterns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMitochondria, HeartDisease ProgressionOxidative StressHumansAnimalsCalciumEnergy MetabolismAdenosine TriphosphateCalcium SignalingCalcium-Calmodulin-Dependent Protein Kinase Type 2

Stichwörter der Autor:innen

ATPCalciumHeart failureMitochondriaRedox

Substanzen

CalciumAdenosine TriphosphateCalcium-Calmodulin-Dependent Protein Kinase Type 2

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, University of Cambridge, Cambridge, UK. ww265@cam.ac.uk.
  • Oxford Centre for Magnetic Resonance Research, University of Oxford, Oxford, UK. ww265@cam.ac.uk.
  • Oxford Centre for Magnetic Resonance Research, University of Oxford, Oxford, UK.
  • Clinical Physiology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Department of Clinical Physiology, Skåne University Hospital, Lund, Sweden.
  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

ORCID-Profile: William D Watson

Zitieren

APA

Watson, W. D., Arvidsson, P. M., Miller, J. J. J., Lewis, A. J., & Rider, O. J. (2024). A Mitochondrial Basis for Heart Failure Progression. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-024-07582-0

Vancouver

Watson WD, Arvidsson PM, Miller JJJ, Lewis AJ, Rider OJ. A Mitochondrial Basis for Heart Failure Progression. Cardiovascular Drugs and Therapy. 2024. doi:10.1007/s10557-024-07582-0

BibTeX
@article{Watson2024,
  author = {Watson, William D and Arvidsson, Per M and Miller, Jack J J and Lewis, Andrew J and Rider, Oliver J},
  title = {A Mitochondrial Basis for Heart Failure Progression},
  journal = {Cardiovascular Drugs and Therapy},
  year = {2024},
  doi = {10.1007/s10557-024-07582-0}
}
Kostenlos starten →